| 000 | 01881nam a2200301 a 4500 | ||
|---|---|---|---|
| 001 | vtls000057260 | ||
| 003 | KUKTEM | ||
| 005 | 20251117150320.0 | ||
| 008 | 111212t2010 flua f 001 0 eng d | ||
| 020 | _a9781420091151 | ||
| 020 | _a1420091158 | ||
| 039 | 9 |
_a201203011027 _bida _c201202281218 _dasmadi _y201112121651 _zshah |
|
| 040 | _aUMP | ||
| 090 | _aRM301.42 .D68 2010 | ||
| 100 | 1 | _aDoucet, Jean Pierre | |
| 245 | 1 | 0 |
_aThree dimensional QSAR : _bapplications in pharmacology and toxicology / _cJean Pierre Doucet, Annick Panaye |
| 260 |
_aBoca Raton, FL : _bCRC Press , _c2010 |
||
| 300 |
_axxxiv, 533 pages, [8] pages of plates : _bill. (some color) ; _c24 cm. |
||
| 490 | 1 | _aQSAR in environmental and health sciences | |
| 504 | _aIncludes bibliographical references and index | ||
| 520 | _a"Experiencing rapid growth over the last 15 years, quantitative structure-activity relationships (QSAR) continue to evolve quickly with an explosion of new tools and techniques. These techniques now play an increasing role in drug design and chemical risk assessment. New molecular descriptors based on three-dimensional structures incorporate a range of classical approaches, including regression and PLS analysis, as well as new nonlinear approaches, such as neural networks and support vector machines. Three-Dimensional QSAR addresses the scope and limitations of different modeling techniques using case studies from pharmacology, toxicology, and ecotoxicology to demonstrate the utility of each technique"--Provided by publisher | ||
| 650 | 0 | _aQSAR (Biochemistry) | |
| 650 | 0 |
_aDrugs _xResearch _xMethodology |
|
| 650 | 0 |
_aToxicology _xResearch _xMethodology |
|
| 700 | 1 | _aPanaye, Annick | |
| 830 | 0 | _aQSAR in environmental and health sciences | |
| 999 |
_aVIRTUA40 _c55872 _d55878 |
||
| 999 | _aVTLSSORT0080*0200*0201*0400*0900*1000*2450*2600*3000*4900*5040*5200*6500*6501*6502*7000*8300*9991 | ||